CD24: A novel cancer biomarker in laryngeal squamous cell carcinoma

ORL

Volumn 74, Issue 2, 2012, Pages 78-85

  Shi, Yong ^a   Gong, Hong Li ^a   Zhou, Liang ^a   Tian, Jie ^a   Wang, Yang ^a  

^a FUDAN UNIVERSITY   (China)

Author keywords

CD24; Immunohistochemistry; Laryngeal squamous cell carcinoma; Proliferating cell nuclear antigen

Indexed keywords

CD24 ANTIGEN; CYCLINE;

ARTICLE; CANCER CELL CULTURE; CANCER INVASION; CANCER STAGING; CELL MIGRATION; CELL PROLIFERATION; HUMAN; HUMAN CELL; HUMAN TISSUE; KAPLAN MEIER METHOD; LARYNGEAL SQUAMOUS CELL CARCINOMA; LARYNX CARCINOMA; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; PROGNOSIS; PROTEIN EXPRESSION; REAL TIME POLYMERASE CHAIN REACTION; SQUAMOUS CELL CARCINOMA;

ANTIGENS, CD24; CARCINOMA, SQUAMOUS CELL; CELL DIVISION; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HEK293 CELLS; HEP G2 CELLS; HUMANS; LARYNGEAL NEOPLASMS; MALE; MIDDLE AGED; NEOPLASM INVASIVENESS; NEOPLASM RECURRENCE, LOCAL; PREDICTIVE VALUE OF TESTS; PROGNOSIS; PROLIFERATING CELL NUCLEAR ANTIGEN; RISK FACTORS; RNA, SMALL INTERFERING; SURVIVAL ANALYSIS; TUMOR MARKERS, BIOLOGICAL;

EID: 84862804208     PISSN: 03011569     EISSN: 14230275     Source Type: Journal    
DOI: 10.1159/000335584     Document Type: Article

References (29)

1. Jemal A, Sieggel R, Ward E, Hao Y, Xu J, Thun MJ: Cancer statistics. CA Cancer J Clin 2009; 59:225-249.
2. Ludwig JA, Weinstein JN: Biomarkers in cancer staging, prognosis and treatment selection. Nat Rev Cancer 2005; 5: 845-856. (Pubitemid 41746029)
3. Leibowitz MS, Nayak JV, Ferris RL: Head and neck cancer immunotherapy: clinical evaluation. Curr Oncol Rep 2008; 10: 162-169. (Pubitemid 351395477)
4. Shurau K, O'Brien PE: Molecular targets in squamous cell carcinoma of the head and neck. Curr Treat Opt Oncol 2008; 8: 239-251.
5. Belov L, de la Vega O, dos Remedios CG, Mulligan SP, Christopherson RI: Immunophenotyping of leukemias using a cluster of differentiation antibody microarray. Cancer Res 2001; 61: 4483-4489. (Pubitemid 32685778)
6. Lee HJ, Kim DI, Kwak C, Ku JH, Moon KC: Expression of CD24 in clear cell renal cell carcinoma and its prognostic significance. Urology 2008; 72: 603-607.
7. Kristiansen G, Schluns K, Yongwei Y, Denkert C, Dietel M, Petersen I: CD24 is an independent prognostic marker of survival in non-small cell lung cancer patients. Br J Cancer 2003; 88: 231-236. (Pubitemid 36255841)
8. Karran L, Jones M, Morley G, Van Noorden S, Smith P, Lampert I, Griffin BE: Expression of a B-cell marker, CD24, on nasopharyngeal carcinoma cells. Int J Cancer 1995; 60: 562-566.
9. Kristiansen G, Winzer KJ, Mayordomo E, Bellach J, Schluns K, Denkert C, Dahl E, Pilarsky C, Altevogt P, Guski H, Dietel M: CD24 expression is a new prognostic marker in breast cancer. Clin Cancer Res 2003; 9: 4906-4913. (Pubitemid 37323297)
10. Yang XR, Xu Y, Yu B, Zhou J, Li JC, Qiu SJ, Shi YH, Wang XY, Dai Z, Shi GM, Wu B, Wu LM, Yang GH, Zhang BH, Qin WX, Fan J: CD24 is a novel predictor for poor prognosis of hepatocellular carcinoma after surgery. Clin Cancer Res 2009; 15: 5518-5527.
11. Sagiv E, Starr A, Rozovski U, Khosravi R, Altevogt P, Wang T, Arber N: Targeting CD24 for treatment of colorectal and pancreatic cancer by monoclonal antibodies or small interfering RNA. Cancer Res 2008; 68: 2803-2812. (Pubitemid 351556279)
12. Smith SC, Oxford G, Wu Z, Nitz MD, Conaway M, Frierson HF, Hampton G, Theodorescu D: The metastasis-associated gene CD24 is regulated by Ral GTPase and is a mediator of cell proliferation and survival in human cancer. Cancer Res 2006; 66: 1917-1922.
13. Baumann P, Cremers N, Kroese F, Orend G, Chiquet-Ehrismann R, Uede T, Yagita H, Sleeman JP: CD24 expression causes the acquisition of multiple cellular properties associated with tumor growth and metastasis. Cancer Res 2005; 65: 10783-10793. (Pubitemid 41715227)
14. Han J, Kioi M, Chu WS, Kasperbauer JL, Strome SE, Puri RK: Identification of potential therapeutic targets in human head and neck squamous cell carcinoma. Head Neck Oncol 2009; 1: 27.
15. Gao Q, Qiu SJ, Fan J, Zhou J, Wang XY, Xiao YS, Xu Y, Li YW, Tang ZY: Intratumoral balance of regulatory and cytotoxic T cells is associated with prognosis of hepatocellular carcinoma after resection. J Clin Oncol 2007; 25: 2586-2593. (Pubitemid 47041232)
16. Yang XY, Xu Y, Shi GM, Fan J, Zhou J, Ji Y, Sun HC, Qiu SJ, Yu B, Gao Q, He YZ, Qin WZ, Chen RX, Yang GH, Wu B, Lu Q, Wu ZQ, Tang ZY: Cytokeratin 10 and cytokeratin 19: predictive markers for poor prognosis in hepatocellular carcinoma patients after curative resection. Clin Cancer Res 2008; 14: 3850-3859.
17. Anghelina F, Ionitǎ E, Popescu CF, Ionita I, Mogoanta C, Ciolofan S, Mogoanta L: Clinical, morphological and immunohistochemical aspects in laryngeal premalignant lesions. Rom J Morphol Embryol 2006; 47: 169-174.
18. Riener MO, Vogetseder A, Pestalozzi BC, Clavien PA, Probst-Hensch N, Kristiansen G, Jochum W: Cell adhesion molecules Pcadherin and CD24 are markers for carcinoma and dysplasia in the biliary tract. Hum Pathol 2010; 41: 1558-1565.
19. Lee HJ, Choe G, Jheon S, Sung SW, Lee CT, Chung JH: CD24, a novel cancer biomarker, predicting disease-free survival of nonsmall cell lung carcinomas: a retrospective study of prognostic factor analysis from the viewpoint of forthcoming (seventh) new TNM classification. J Thorac Oncol 2010; 5: 649-657.
20. Ahmed MA, Al-Attar A, Kim J, Watson NF, Scholefield JH, Durrant LG, Ilyas M: CD24 shows early upregulation and nuclear expression but is not a prognostic marker in colorectal cancer. J Clin Pathol 2009; 62: 1117-1122.
21. Claudio PP, Russo G, Kumar CA, Minimo C, Farina A, Tutton S, Nuzzo G, Giuliante F, Angeloni G, Maria V, Vecchio FM, Campli CD, Giordano A: pRb2/p130, vascular endothelial growth factor, p27(KIP1), and proliferating cell nuclear antigen expression in hepatocellular carcinoma: their clinical significance. Clin Cancer Res 2004; 10: 3509-3517. (Pubitemid 38685460)
22. Sagiv E, Kazanov D, Arber N: CD24 plays an important role in the carcinogenesis process of the pancreas. Biomed Pharmacother 2006; 60: 280-284. (Pubitemid 44223938)
23. Sagiv E, Memeo L, Karin A, Kazanov D, Jacob-Hirsch J, Mansukhani M, Rechavi G, Hibshoosh H, Arber N: CD24 is a new oncogene, early at the multistep process of colorectal cancer carcinogenesis. Gastroenterology 2006; 131: 630-639. (Pubitemid 44142443)
24. Kristiansen G, Pilarsky C, Pervan J, Sturzebecher B, Stephan C, Jung K, Loening S, Rosental A, Dietel K: CD24 expression is a significant predictor of PSA relapse and poor prognosis in low grade or organ confined prostate cancer. Prostate 2004; 58: 183-192. (Pubitemid 38160906)
25. Kristiansen G, Sammar M, Altevogt P: Tumour biological aspects of CD24, a mucinlike adhesion molecule. J Mol Histol 2004; 35: 255-262. (Pubitemid 40585311)
26. Weichert W, Denkert C, Burkhardt M, Gansukh T, Bellach J, Altevogt P, Dietel M, Kristiansen G: Cytoplasmic CD24 expression in colorectal cancer independently correlates with shortened patient survival. Clin Cancer Res 2005; 11: 6574-6581. (Pubitemid 41338997)
27. Shapira S, Shapira A, Starr A, Kazanov D, Kraus S, Benhar I, Arber N: An immunoconjugate of anti-CD24 and Pseudomonas exotoxin selectively kills human colorectal tumors in mice. Gastroenterology 2011; 140: 935-946.
28. Meng F, Henson R, Wehbe-Janek H, Ghoshal K, Jacob ST, Patel T: MicroRNA-21 regulates expression of the PTEN tumor suppressor gene in human hepatocellular cancer. Gastroenterology 2007; 133: 647-658. (Pubitemid 47187346)
29. Liu M, Wu H, Liu T, Li Y, Wang F, Wan H, Li X, Tang H: Regulation of the cell cycle gene, BTG2 , by miR-21 in human laryngeal carcinoma. Cell Res 2009; 19: 828-837.